Collaborative research & grants
Radiomics has many national and international collaborations with universities, hospitals, research centers and other SMEs. We are currently involved in projects with the University Hospital of Liege, the University of Maastricht, Memorial Sloan Kettering Cancer Center, German Cancer Research Center (DKFZ), Istituto Europeo di Oncologia, University of Aachen, University of Wollongong in Dubai, Albert Einstein College of Medicine, Spectra Health Ghana.
We are partners and lead in several European and regional research projects funded by the European Union Horizon 2020 research and innovation program, the Innovative Medicine initiative (IMI) joint undertaking, Eurostars and the Interreg EMR program.
The rapid and secure AI enhanced diagnosis, precision medicine and patient empowerment centered decision support system for Coronavirus pandemics. Innovative medicine initiative (IMI) call H2020-JTI-IMI2-2020-21. € 11.54M (2020-2023)
A European Cancer Image Platform Linked to Biological and Health Data for Next-Generation Artificial Intelligence and Precision Medicine in Oncology. H2020 Research and Innovation action (RIA) call H2020-SC1-FA-DTS-2018-2020. € 9.99M (2020-2024)
Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine. H2020 Research and Innovation action (RIA) call H2020-SC1-BHC-2018-2020. € 19.3M (2020-2024)
The Euradiomics project aims at setting up an Imaging-based Big Data for decision support system for cancer: productization and sustainable research and development of Radiomics products, EMR4, Interreg EMR. € 3.40M (2017 – 2020)
A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostic in oncology. MARIE SKŁODOWSKA-CURIE ACTIONS, Innovative Training Networks (ITN) Call: H2020-MSCA-ITN-2017. € 3.58M (2017-2021)
Cloud based decision support system for personalized and participatory cancer therapy selection. Eurostars E!11541. €1.91M (2017-2020)
The application of deep learning in contrast enhanced mammography: towards a virtual breast biopsy. Eurostars E!12931. €1.51M (2019-2022)